Milgamma (Benfotiamine, Cyanocobalamin)

Milgamma, containing benfotiamine and cyanocobalamin, is used in conditions related to nerve health and vitamin deficiencies.

• Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory disturbances associated with diabetes.
• Peripheral neuropathy: supports nerve function and may reduce discomfort in non‑diabetic neuropathic conditions.
• Vitamin B1 deficiency: provides bioavailable thiamine to correct deficiency states.
• Vitamin B12 deficiency: supplies cyanocobalamin to restore normal B12 levels and support hematologic and neurologic health.

• Benfotiamine is a lipid‑soluble thiamine derivative that readily crosses cell membranes, increasing intracellular thiamine diphosphate and inhibiting formation of advanced glycation end‑products. Cyanocobalamin serves as a source of vitamin B12, participating in DNA synthesis, methylation cycles and the formation of myelin sheaths, thereby supporting neuronal integrity and hematopoiesis.

Milgamma is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild gastrointestinal upset reported by some users.
• Headache: transient headache may be experienced.
• Skin rash: mild erythematous rash at the site of contact.
• Diarrhea: occasional loose stools.
• Dyspepsia: mild indigestion or abdominal discomfort.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Angioedema: swelling of face, lips or throat.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hematologic abnormalities: rare cases of pancytopenia.
• Neurological worsening: unexpected exacerbation of neuropathic symptoms.

Before initiating Milgamma, consider the following safety measures.

• Assess vitamin status: evaluate baseline B1 and B12 levels when possible.
• Monitor hypersensitivity: discontinue if signs of allergic reaction appear.
• Renal impairment: use with caution in patients with reduced kidney function.
• Drug interactions: review concomitant medications that may affect B‑vitamin metabolism.
• Pregnancy and lactation: consult a healthcare professional before use.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Milgamma may interact with other medicines; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid)

• Methotrexate: may increase toxicity due to altered folate metabolism.
• Phenytoin: can reduce cyanocobalamin absorption, diminishing efficacy.
• Chloramphenicol: may interfere with vitamin B12 utilization.

Moderate Interactions (Monitor Closely)

• Metformin: long‑term use can lower B12 levels, requiring periodic monitoring.
• Proton pump inhibitors: may decrease B12 absorption from the gut.
• Alcohol: excessive intake raises thiamine requirements and may blunt benfotiamine benefits.